← Back to Clinical Trials
Recruiting NCT07580456

NCT07580456 AI for Gastric POCUS ( Point-of-care Ultrasound)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07580456
Status Recruiting
Phase
Sponsor University Health Network, Toronto
Condition Point-of-care Ultrasound
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2026-05-05
Primary Completion 2027-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2026-05-05 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to train and test an AI (Artificial Intelligence)-based program to assist anesthesiologists in the interpretation of stomach ultrasound images and differentiate a "full" from an "empty" stomach. It is a healthy-volunteer study, where the participants will undergo ultrasound examination of their stomach at three different time points to visualize the stomach contents. These are at fasting state, after taking some solid food and after taking some water. Here, the participants will be randomized to receive one of five different types solid foods and one of five different volumes of water. The stomach ultrasound images will then be used to train and test the accuracy of the model to diagnose the type of stomach content (nothing vs. clear fluid vs. solid food)

Eligibility Criteria

Inclusion Criteria: A. Inclusion Criteria at the level of the participants * Participants must meet all the following inclusion criteria to be eligible for the study: * Aged ≥18 years * Any sex * Be healthy B. Inclusion Criteria at the level of the input data • Transverse ultrasound images (10 sec clips) of the gastric antrum in the epigastric area that contain all these structures: * The edge of the left lobe of the liver * The gastric antrum * The pancreas * The aorta Exclusion Criteria: A. Exclusion Criteria at the level of the participants * Participants meeting any of the following exclusion criteria are ineligible for the study: * Previous gastro-esophageal surgery (e.g., gastric by-pass, sleeve gastrectomy, fundoplication, partial gastrectomy) * Allergy to any of the food that will be provided. B. Exclusion Criteria at the level of the input data • Ultrasound images (10 sec clips) where the gastric antrum cannot be positively identified.

Contact & Investigator

Central Contact

Jayanta Chowdhury, MBBS,MD

✉ jayanta.chowdhury@uhn.ca

📞 416-603-5800

Principal Investigator

Anahi Perlas

PRINCIPAL INVESTIGATOR

University Health Network, Toronto

Frequently Asked Questions

Who can join the NCT07580456 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Point-of-care Ultrasound. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07580456 currently recruiting?

Yes, NCT07580456 is actively recruiting participants. Contact the research team at jayanta.chowdhury@uhn.ca for enrollment information.

Where is the NCT07580456 trial being conducted?

This trial is being conducted at Toronto, Canada.

Who is sponsoring the NCT07580456 clinical trial?

NCT07580456 is sponsored by University Health Network, Toronto. The principal investigator is Anahi Perlas at University Health Network, Toronto. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology